banda transcan 2 2016ul

The ERA-NET: Aligning national/regional translational cancer research programmes and activities - TRANSCAN-2 is a five-year project (2015-2019) funded by the European Commission under the EU framework programme Horizon2020 (Grant Agreement no. 643638).

It is the continuation of the previous ERA-NET on translational cancer research TRANSCAN, funded under the FP7 from 2011 to 2014.

TRANSCAN-2 is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 28 partners from 19 Countries.

 


Coordination:
The project is coordinated by the Ministry of Health, Italy
Coordinator: Dr. Giovanni Leonardi. Deputy coordinator: Dr. Gaetano Guglielmi
 
Contact:
Dr. Silvia Paradisi
Project Manager
Italian National Institute of Health
Viale Regina Elena, 299
00161 Rome, Italy
 
mail to: This email address is being protected from spambots. You need JavaScript enabled to view it.


TRANSCAN-2 News


CLOSED CALL

 Fourth Joint Transnational Call 2017 (JTC 2017)

on: Translational Research on Rare Cancers

 Deadline for submission of pre-proposals: February 6th, 2018

visit the page


JTC 2016

on: “Minimally and non-invasive methods for early detection and/or progression of cancer"

14 projects selected for funding 

visit the page


 

Newsletters

Newsletter 6, June 2108

Newsletter 5, March 2018

Newsletter 4, December 2017

Newsletter 3, September 2017

Newsletter 2, April 2017

Newsletter 1, December 2016

To subscribe to TRANSCAN-2 newsletter mailing list please send an email to: This email address is being protected from spambots. You need JavaScript enabled to view it.

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.